Navigation Links
RiOs 50 Water System

ProductsRiOs 50 Water System
Company Millipore
Item RiOs 50 Water System
Features Inquire
Description Produce Up to 8000 L/day of Type III Laboratory-grade Water
RiOs reverse osmosis systems are designed to produce up to 8000 L/day of Type III laboratory-grade water from potable tap feedwater.

One Complete Purification and Control Unit
RiOs systems can be integrated into a centralized system, providing total control of all parameters within the system itself as well as within the external pure water distribution loop. Applications

  • Glassware rinsing
  • Feedwater for humidifiers, autoclaves and washing machines
  • Feedwater for Milli-Q and Super-Q ultrapure water systems
      • Features
      • Total control of all functions, operating parameters and standard accessory components within the RiOs system itself and within the external pure water distribution loop
      • Advanced reverse osmosis allows for high water recovery
      • Constant product flow rate independent of temperature from 7 - 30 C
      • Built-in UV lamp for bacteria-sensitive applications
      • Easy-to-replace pretreatment packs, tailored to the feedwater source
      • Built-in resistivity monitoring to ensure water quality
Info Millipore
Customer Service: (978) 715-4321
Web site: http://www.millipore.com/

Related medicine products :

1. HydroKeratome Waterjet System
2. US Autoflow Single Chamber Stackable Water-Jacketed CO2/O2 Inc.
3. IR Autoflow Single Chamber Water-Jacketed CO2 Incubator
4. US Autoflow Single Chamber Stackable Water-Jacketed CO2 Inc.w/ Humidity Display and Control
5. IR Autoflow Dual Chamber Over-Under Water-Jacketed CO2 Inc.
6. Vibratome 900 R Closed Loop Water System
7. CFI Fluor 20x Water Dipping Objective
8. Innova 3100 Water Bath Shaker
9. NBS C76 Water Bath Shaker
10. pH 200 series, F 295 Handheld, Water-Proof pH/Temp/mV/ISE Meter
11. pH 200 series, F 265 Handheld, Water-Proof pH/Temp/mV Meter With Electrode
Angled insertion forcep used for the Hydroview lens. Manufactured in titanium.
Biconvex jaw design. 40 degree angled shafts. Tip to angle length: 7.5 mm. Locking handle. Manufacturing in titanium.
Titanium. Designed to easily fold the hydroview lens. Will also fold many styles of soft intraocular lenses. Unique cross-action design facilitates folding of the lens.
Curved shafts with serrated 1.5 mm upper and 2 mm lower jaws. Serrated cross action handle with slide lock and polished finish. Most popular size or model.
Medicine Products:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...ropriate weight, according to current guidelines,/...nadequate weight to have a baby who becomes overwe... new study at the Department of Ambulatory Care an...d Pilgrim Health Care and are published in the Apr...
...y signs of cervical cancer and providing //prevent..., acceptable to women and feasible, according to a...School of Medicine. If this technique can be sca...vent one of the leading causes of cancer death in ...
... effects of antioxidants such as vitamin C.// Scie...the presence of lipid the ability of antioxidants,...tamin C), to protect against the generation of pot... less than when no lipids are present. “Our result...
...own and dirty say researchers from Bristol Univers...y led by Dr. Chris Lowry and team, claims that t...ccae, can actually replicate the effects of anti- ...sprung from reports of lung cancer patients who w...
Other Medicine News:Health News:Weight Gain in Pregnancy Linked to Overweight in Kids 2Health News:Weight Gain in Pregnancy Linked to Overweight in Kids 3Health News:1-visit Screening, Prevention for Cervical Cancer Holds Promise 2Health News:Be Happy- Get On Your Knees And Play In The Mud 2
(Date:9/5/2008)...ANTOWN, W.Va., Sept. 5 /PRNewswire-USNewswire/ -- ...e mental fog known as chemobrain. Now in,animal st...e discovered,that injections of N-acetyl cysteine ... that breast cancer chemotherapy drugs sometimes i...in the September issue of the,journal Metabolic Br...
(Date:9/4/2008)...OURNE, Australia, Sept. 4 /- Cytopia ...encing enrolment for its Phase Ib/II,study of CYT9...ncer agent,in patients with an aggressive form of...M)., The GBM clinical trial is the first Phase II...dications for the company and the second in its,su...
(Date:9/4/2008)...tice Bulletin for Obstetrician-Gynecologists State... Change-Minimally Invasive Interventional,Radiolog...th Uterine,Fibroids, FAIRFAX, Va., Sept. 4 /PRNew... Radiology, a national organization of nearly 4,50...als dedicated to improving health,care through min...
(Date:9/4/2008)... cohort demonstrates potent antiviral activity and...ofile -, CAMBRIDGE, Mass., Sept. 4 /PRNewswire-Fi... IDIX ), a biopharmaceutical company engaged,in th...ment of human viral,and other infectious diseases,...f-concept study evaluating IDX899, a non-nucleosid...
Breaking Medicine Technology:Study Suggests a Possible Way to Offset Chemobrain Memory Loss 2Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Westaim announces 2008 second quarter results 25389 1Westaim announces 2008 second quarter results 25389 2Westaim announces 2008 second quarter results 25389 3Westaim announces 2008 second quarter results 25389 4West Coast Bank Sponsors LifeWorks Northwest Programs for Children in Low Income Housing Communities 25385 1West Coast Bank Sponsors LifeWorks Northwest Programs for Children in Low Income Housing Communities 25385 2New robot scouts best locations for components of undersea lab 4453 1New robot scouts best locations for components of undersea lab 4453 2New robot scouts best locations for components of undersea lab 4453 3POET Announces That Cellulosic Ethanol Pilot Facility Will Be Operational This Year 7124 1POET Announces That Cellulosic Ethanol Pilot Facility Will Be Operational This Year 7124 2POET Announces That Cellulosic Ethanol Pilot Facility Will Be Operational This Year 7124 3
...Md.--(BUSINESS WIRE)--Apr 17, 2007 - GenVec, Inc.,...s presented at,the 97th annual meeting of the Amer...rther support the use of adenovector systems,to de...F(alpha)).,GenVec,s lead product candidate, TNFera...NA carrier, which contains the gene for,TNF(alpha)...
... 17, 2007 /PRNewswire/ -- Addex Pharmaceuticals,an... IIa proof of,concept trial with its lead compound...x disease (GERD), a highly prevalent,condition wit...eved,its primary objective, the control of 24-hour... also showed statistically significant,improvement...
Other Medicine Technology:GenVec Announces New Research at AACR on Selectivity and Mechanism,of Action of TNF-Based Anti-Cancer Therapy 2GenVec Announces New Research at AACR on Selectivity and Mechanism,of Action of TNF-Based Anti-Cancer Therapy 3Addex Achieves Statistically Significant Outcome in Phase IIa,Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease 2Addex Achieves Statistically Significant Outcome in Phase IIa,Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease 3Addex Achieves Statistically Significant Outcome in Phase IIa,Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease 4Addex Achieves Statistically Significant Outcome in Phase IIa,Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease 5